Korro Bio
KRRO
40 hedge funds and large institutions have $302M invested in Korro Bio in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 2 reducing their positions, and 18 closing their positions.
2,298% more capital invested
Capital invested by funds: $12.6M → $302M (+$289M)
650% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 2
81.45% more ownership
Funds ownership: 0.58% → 82.03% (+81%)
6% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 18
2% less funds holding
Funds holding: 41 → 40 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AVLSA
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
|
+$36.9M |
| 2 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$35.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$24M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$17.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$16.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$444K |
| 2 |
Goldman Sachs
New York
|
-$78.5K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$50K |
| 4 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
-$46.1K |
| 5 |
WPW
Waldron Private Wealth
Bridgeville,
Pennsylvania
|
-$26.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Bank of New York Mellon
New York
| – | -$5.89K | -319 | Closed |
|
|
HF
52
HRT Financial
New York
| – | -$5K | -294 | Closed |
|
53
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$4.39K | -240 | Closed |
|
54
Two Sigma Advisers
New York
| – | -$3.77K | -204 | Closed |
|
|
CG
55
Cutler Group
San Francisco,
California
| – | -$2K | -136 | Closed |
|
|
SWM
56
Spire Wealth Management
Mclean,
Virginia
| – | -$725 | -39 | Closed |
|
57
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$370 | -20 | Closed |
|
KRRO Hedge Fund Activity: Q4 2023 in Review
40 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q4 2023, worth a combined $302M — up 2,298% from $12.6M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of KRRO and 17 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 15 added.
The largest buyer was Atlas Venture Life Science Advisors, opening a new position worth an estimated $36.9M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $444K sold.
- 40 institutional investors held Korro Bio (KRRO) as of Q4 2023, down from 41 in Q3 2023.
- Funds reported $302M of Korro Bio stock for Q4 2023, up 2,298% quarter-over-quarter.
- 17 funds opened new Korro Bio positions in Q4 2023 and 18 closed out, a net change of -1 holder.
- The largest Korro Bio buyer in Q4 2023 was Atlas Venture Life Science Advisors, an estimated $36.9M added.
- The largest Korro Bio seller in Q4 2023 was Adage Capital Partners, an estimated $444K sold.
Based on aggregated 13F filings for Q4 2023.